Indications and uses
USE: HELPS TREAT ACNE PIMPLES AND ALLOWS SKIN TO HEAL.
ClearPrep FX
- Manufacturer
- Cover FX Skin Care, Inc.
- Effective date
- 2013-02-19
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:34:38
Label at a glance#
ProductClearPrep FX
Active ingredientSALICYLIC ACID
Label structure10 sections
Dosage and administration
PRIME YOUR SIN WITH THIS LIGHTWEIGHT GEL PRIMER, TO IMPROVE BLENDING AND WEAR. DERMAVEIL BLURS THE APPEARANCE OF PORES AND FINE LINES. AFRICAN TREE BARK EXTRACT NATURALLY HELPS REDUCE SHINE. EXPERIENCE A BLEND OF BOTANICAL EXTRACTS THAT HELP PROMOTE SMOOTHER LOOKING SKIN. DIRECTIONS: CLEANSE SKIN THOROUGHLY BEFORE APPLYING THE PRODUCT. APPLY PRODUCT TO AFFECTED AREAS ONE TO THREE TIMES DAILY OR AS DIRECTED BY A HE...
Contacts and useful links#
Websitewww.sifprogram.org
WWW.SIFPROGRAM.ORG
WWW.SIFPROGRAM.ORGLabel contents#
Full prescribing information#
Active Ingredients Section
SALICYLIC ACID 1%
Purpose Section
MATTE FOUNDATION PRIMER AND ANTI-ACNE TREATMENT GEL
Indications and Uses Section
USE: HELPS TREAT ACNE PIMPLES AND ALLOWS SKIN TO HEAL.
Warning Section
WARNINGS: FOR EXTERNAL USE ONLY. USING OTHER TOPICAL ACNE PRODUCTS AT THE SAME TIME OR IMMEDIATELY FOLLOWING USE OF THIS PRODUCT MAY INCREASE DRYNESS OR IRRITATION OF THE SKIN. IF THIS OCCURS, ONLY ONE PRODUCT SHOULD BE USED UNLESS DIRECTED BY A HEALTH CARE PRACTITIONER.
THIS PRODUCT CONTAINS AN ALPHAHYDROXY ACID (AHA) THAT MAY INCREASE YOUR SKINS SENSITIVITY TO THE SUN AND PARTICULARLY THE POSSIBILITY OF SUNBURN. PLEASE LIMIT SUN EXPOSURE AND APPLY SUNBURN PROTECTANT WHILE USING THIS PRODUCT AND FOR A WEEK AFTERWARDS.
DO NOT USE IF TUBE SEAL HAS BEEN TAMPERED WITH.
Caution Section
CAUTION: DISCONTINUE USE IF SKIN IRRITATION DEVELOPS OR INCREASES. IF IRRITATION PERSISTS, CONTACT A HEALTH CARE PRACTITIONER. AVOID CONTACT WITH THE EYES; IF CONTACT OCCURS, RINSE THOROUGHLY WITH WATER.
Report Adverse Section
YOU MAY REPORT A SERIOUS ADVERSE AFFECT FROM THIS PRODUCT TO (USA) COVER FX 33 ELM STREET, SUITE 377, CHAMPLAIN, NY 2919 (CANADA) COVER FX 1681 FLINT RD, TORONTO, ON M3J 2W8
Directions Section
PRIME YOUR SIN WITH THIS LIGHTWEIGHT GEL PRIMER, TO IMPROVE BLENDING AND WEAR. DERMAVEIL BLURS THE APPEARANCE OF PORES AND FINE LINES. AFRICAN TREE BARK EXTRACT NATURALLY HELPS REDUCE SHINE. EXPERIENCE A BLEND OF BOTANICAL EXTRACTS THAT HELP PROMOTE SMOOTHER LOOKING SKIN.
DIRECTIONS: CLEANSE SKIN THOROUGHLY BEFORE APPLYING THE PRODUCT. APPLY PRODUCT TO AFFECTED AREAS ONE TO THREE TIMES DAILY OR AS DIRECTED BY A HEALTH CARE PRACTITIONER.
Inactive Ingredient Section
INACTIVE INGREDIENTS: CYCLOPENTASILOXANE AQUA DIMETHICONE CROSSPOLYMER BUTYLENE GLYCOL DIMETHICONE SALIX NIGRA (WILLOW) BARK EXTRACT BIS-PEG/PPG-14/14 DIMETHICONE GLYCERIN SQUALANE VACCINIUM MYRTILLUS (BILBERRY) FRUIT EXTRACT CAPRYLIC/CAPRIC TRIGLYCERIDE DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER CETYL PEG/PPG-10/1 DIMETHICONE POLYMETHYLSILSESQUIOXANE SACCHARUM OFFICINARUM (SUGER CANE) EXTRACT PHENYL METHICONE BISABOLOL HYDROLYZED MILK PROTEIN TOCOPHERYL ACETATE DIMETHICONOL PEG-60 ALMOND GLYCERIDES PROPYLENE GLYCOL CITRUS AURANTIUM DULCIS (ORANGE) FRUIT EXTRACT CITRUS MEDICA LIMONUM (LEMON) FRUIT EXTRACT CAPRYLYL GLYCOL BENZYL ALCOHOL SILICA ENANTIA CHLORANTHA BARK EXTRACT LINOLEIC ACID LINOLENIC ACID ACER SACCHARUM (SUGAR MAPLE) EXTRACT TETRAHEXYLDECYL ASCORBATE BENZOIC ACID CARBOMER SORBIC ACID RETINYL PALMITATE POLYSORBATE 20 CITRUS AURANTIUM (NEROLI) OIL OLEANOLIC ACID NORDIHYDROGUAIARECTIC ACID PALMITOYL OLIGOPEPTIDE PALMITOYL TETRAPEPTIDE-7
Keep Out of Reach of Children Section
Enter section text here
Label Section
CLEARPREPFX MATTE FOUNDATION PRIMER AND ANTI-ACNE TREATMENT GEL
CRUELTY FREE SUSTAINABLE FORESTRY INITIATIVE CERTIFIED CHAIN OF CUSTODY WWW.SIFPROGRAM.ORG
COVER FX DIST. BY/PAR COVER FX SKIN CARE INC. TORONTO, ONTARIO CANADA M3J 2W8. LONDON W1V 2LD
DERMATOLOGISTS FIRST CHOICE
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68327-006-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b401-f424-e053-dadaa90a57ce | 5889aae9-6224-4cb1-a184-67a76597a48c |
| 68327-006-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b401-f424-e053-dadaa90a57ce | 5889aae9-6224-4cb1-a184-67a76597a48c |
| 68327-006-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b401-f424-e053-dadaa90a57ce | 5889aae9-6224-4cb1-a184-67a76597a48c |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68327-006-01 | ClearPrep FX | 30 mL in 1 TUBE | GEL | 30 | 1 | |
| 68327-006-02 | ClearPrep FX | 15 mL in 1 TUBE | GEL | 15 | 1 | |
| 68327-006-03 | ClearPrep FX | 7 mL in 1 TUBE | GEL | 7 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SALICYLIC ACID | ACTIVE INGREDIENT | O414PZ4LPZ | 1 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 1 | |
| ACER SACCHARUM BARK/SAP | INACTIVE INGREDIENT | Z120VL0KAC | 1 | |
| ALPHA-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| ANNICKIA CHLORANTHA BARK | INACTIVE INGREDIENT | H70115MP4A | 1 | |
| BENZOIC ACID | INACTIVE INGREDIENT | 8SKN0B0MIM | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | 1 | |
| BILBERRY | INACTIVE INGREDIENT | 9P2U39H18W | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | INACTIVE INGREDIENT | 4Q93RCW27E | 1 | |
| CASEIN | INACTIVE INGREDIENT | 48268V50D5 | 1 | |
| CETYL PEG/PPG-10/1 DIMETHICONE (HLB 5) | INACTIVE INGREDIENT | 035JKJ76MT | 1 | |
| CITRUS AURANTIUM FLOWER OIL | INACTIVE INGREDIENT | D4BGE91OXH | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| DIMETHICONE/DIENE DIMETHICONE CROSSPOLYMER | INACTIVE INGREDIENT | RSA9I561OK | 1 | |
| DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) | INACTIVE INGREDIENT | 9E4CO0W6C5 | 1 | |
| DIMETHICONOL (40 CST) | INACTIVE INGREDIENT | 343C7U75XW | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| LEMON | INACTIVE INGREDIENT | 24RS0A988O | 1 | |
| LEVOMENOL | INACTIVE INGREDIENT | 24WE03BX2T | 1 | |
| LINOLEIC ACID | INACTIVE INGREDIENT | 9KJL21T0QJ | 1 | |
| LINOLENIC ACID | INACTIVE INGREDIENT | 0RBV727H71 | 1 | |
| MASOPROCOL | INACTIVE INGREDIENT | 7BO8G1BYQU | 1 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| OLEANOLIC ACID | INACTIVE INGREDIENT | 6SMK8R7TGJ | 1 | |
| ORANGE | INACTIVE INGREDIENT | 5EVU04N5QU | 1 | |
| PALMITOYL OLIGOPEPTIDE | INACTIVE INGREDIENT | HO4ZT5S86C | 1 | |
| PALMITOYL TETRAPEPTIDE-7 | INACTIVE INGREDIENT | Q41S464P1R | 1 | |
| PEG-60 ALMOND GLYCERIDES | INACTIVE INGREDIENT | 4Y0E651N0F | 1 | |
| PHENYL TRIMETHICONE | INACTIVE INGREDIENT | DR0K5NOJ4R | 1 | |
| POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) | INACTIVE INGREDIENT | 59Z907ZB69 | 1 | |
| POLYSORBATE 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| SALIX NIGRA BARK | INACTIVE INGREDIENT | QU52J3A5B3 | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SORBIC ACID | INACTIVE INGREDIENT | X045WJ989B | 1 | |
| SQUALANE | INACTIVE INGREDIENT | GW89575KF9 | 1 | |
| SUGARCANE | INACTIVE INGREDIENT | 81H2R5AOH3 | 1 | |
| TETRAHEXYLDECYL ASCORBATE | INACTIVE INGREDIENT | 9LBV3F07AZ | 1 | |
| VITAMIN A PALMITATE | INACTIVE INGREDIENT | 1D1K0N0VVC | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- ClearPrep FX
- SALICYLIC ACID
- CYCLOMETHICONE 5
- WATER
- DIMETHICONE/DIENE DIMETHICONE CROSSPOLYMER
- BUTYLENE GLYCOL
- DIMETHICONE
- SALIX NIGRA BARK
- GLYCERIN
- SQUALANE
- BILBERRY
- MEDIUM-CHAIN TRIGLYCERIDES
- DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE)
- CETYL PEG/PPG-10/1 DIMETHICONE (HLB 5)
- POLYMETHYLSILSESQUIOXANE (4.5 MICRONS)
- SUGARCANE
- PHENYL TRIMETHICONE
- LEVOMENOL
- CASEIN
- ALPHA-TOCOPHEROL ACETATE
- DIMETHICONOL (40 CST)
- PEG-60 ALMOND GLYCERIDES
- PROPYLENE GLYCOL
- ORANGE
- LEMON
- CAPRYLYL GLYCOL
- BENZYL ALCOHOL
- SILICON DIOXIDE
- ANNICKIA CHLORANTHA BARK
- LINOLEIC ACID
- LINOLENIC ACID
- ACER SACCHARUM BARK/SAP
- TETRAHEXYLDECYL ASCORBATE
- BENZOIC ACID
- CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)
- SORBIC ACID
- VITAMIN A PALMITATE
- POLYSORBATE 20
- CITRUS AURANTIUM FLOWER OIL
- OLEANOLIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 68327-006 | 68327-006-01, 68327-006-02, 68327-006-03 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SUSPENSION / INTRASYNOVIAL | 18 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / TOPICAL | 4886 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, METERED / RECTAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, DELAYED RELEASE / ORAL | 1.7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / INTRAVENOUS | 5 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / RECTAL | 27 mg | ||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | GEL / TRANSDERMAL | 150 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 69 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TAMPON / VAGINAL | 62.1 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | AEROSOL, FOAM / VAGINAL | 0.1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | GEL / TOPICAL | 12 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | CONCENTRATE / ORAL | 12.5 mg/5ml | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | CREAM / TOPICAL | 14 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | TABLET, DELAYED RELEASE / ORAL | 0.03 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 144 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / RECTAL | 1214 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SOLUTION / ORAL | 336 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 63.4 %w/v | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SOAP / TOPICAL | 0.02 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION, EXTENDED RELEASE / ORAL | 1000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / TOPICAL | 1800 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 19 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER / SUBLINGUAL | 2 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION, CONCENTRATE / ORAL | 2590 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SPRAY, METERED / NASAL | 5 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | CLOTH / TOPICAL | NA | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SOLUTION / INTRAVENOUS | 242 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / AURICULAR (OTIC) | 0.9 %w/v | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | PELLET / ORAL | 34 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | PASTE / DENTAL | 34 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, EXTENDED RELEASE / TRANSDERMAL | 49 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / RESPIRATORY (INHALATION) | 10 %w/w | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | TABLET / ORAL | 10 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / SUBCUTANEOUS | 1.4 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | TABLET / ORAL | 1.06 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY, METERED / NASAL | 240 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SOLUTION / ORAL | 280 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / NASAL | 5 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / OPHTHALMIC | 1 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION/ DROPS / OPHTHALMIC | 0.75 %w/v | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | MOUTHWASH / BUCCAL | NA | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRALESIONAL | 23 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 05ed1245-f8fd-45d1-85ad-5dad98bf568e | 5889aae9-6224-4cb1-a184-67a76597a48c | 2013-02-19 | Warnings, Adverse reactions | 05ed1245-f8fd-45d1-85ad-5dad98bf568e 5889aae9-6224-4cb1-a184-67a76597a48c |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.